TARDBP and nasopharyngeal carcinoma: In turn, we demonstrate two approaches to reduce CHMP2B protein expression, namely siRNA and ASO mediated knockdown, that abrogate sustained “over-activation” of Nup turnover thereby alleviating pathophysiologic events associated with NPC injury including POM121 expression and TDP-43 dysfunction.